|
UPRT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.07531777821168E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66044955562938E-12 |
| Normal-vs-Stage2 |
1.577810E-04 |
| Normal-vs-Stage3 |
3.7279999998141E-07 |
| Normal-vs-Stage4 |
4.60379956379597E-10 |
| Stage1-vs-Stage2 |
3.765800E-01 |
| Stage1-vs-Stage3 |
8.201000E-01 |
| Stage1-vs-Stage4 |
6.806300E-02 |
| Stage2-vs-Stage3 |
5.688000E-01 |
| Stage2-vs-Stage4 |
4.644200E-02 |
| Stage3-vs-Stage4 |
1.103230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.43849426498855E-15 |
| Normal-vs-AfricanAmerican |
6.57680000459848E-08 |
| Normal-vs-Asian |
1.261570E-01 |
| Caucasian-vs-AfricanAmerican |
1.128760E-01 |
| Caucasian-vs-Asian |
4.929600E-01 |
| AfricanAmerican-vs-Asian |
9.995200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
8.5185999998405E-07 |
| Male-vs-Female |
5.5562000000009E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.46790002375496E-09 |
| Normal-vs-Extreme_Weight |
1.64390723256247E-12 |
| Normal-vs-Obese |
2.11439754593812E-11 |
| Normal-vs-Extreme_Obese |
1.685580E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.529600E-01 |
| Normal_Weight-vs-Obese |
9.720200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.442400E-01 |
| Extreme_Weight-vs-Obese |
2.852000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.992600E-01 |
| Obese-vs-Extreme_Obese |
4.460000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.41279999985333E-07 |
| Normal-vs-Age(41-60Yrs) |
3.50053319664312E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62558855265615E-12 |
| Normal-vs-Age(81-100Yrs) |
1.230990E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.168000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.231000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.553600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.754400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.101600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.260800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62525548574877E-12 |
| Normal-VS-Type2 PRCC |
2.55800047810339E-10 |
| Normal-VS-KIRP CIMP |
2.00269999999225E-05 |
| Normal-VS-Unclassified PRCC |
2.97490000411571E-08 |
| Type1 PRCC-VS-Type2 PRCC |
8.213900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.497800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.100600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.093800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.327600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.878000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.63830077176885E-11 |
| Normal-vs-N1 |
2.426000000888E-08 |
| Normal-vs-N2 |
9.97449999999844E-05 |
| N0-vs-N1 |
8.776200E-01 |
| N0-vs-N2 |
6.981000E-01 |
| N1-vs-N2 |
6.350200E-01 |
|
|
